MHRA’s new corporate plan sets out goals for patient safety and access to innovative medical products

FHS
July 4, 2023
1:57 pm

A new, visionary Corporate Plan, setting out how the Medicines and Healthcare products Regulatory Agency plans to keep patients safe by enabling access to innovative, safe and effective medical products over the coming three years, has been published today (4 July 2023).

Implant for Ocular Hypertension, Glaucoma Gets FDA Green Light

The FDA approved the travoprost intracameral implant (iDose TR) for treatment of ocular hypertension and glaucoma, device developer Glaukos announced on Thursday. The implant is

December 15, 2023

Early childhood biases fuel wealth inequality

Income and wealth inequality in the U.S. remain near all-time highs. Analysts say this disparity is a “major issue of our time.” Experts have spotlighted

September 19, 2024

Cancer is a killer. So is the fear of it

The widespread attention to the recent revelations of cancer diagnoses by Princess Catherine, actress Olivia Munn, and King Charles, among others, demonstrate yet again that

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.